Investor Overview

Webcast ImageWebcast
Capnia Inc at the BIO CEO & Investor Conference  (Replay)
02/14/17 at 8:00 a.m. ET

Corporate Profile

We develop novel products based on our proprietary technologies for precision metering of gas flow. Our first commercial product, the CoSense® ETCO Monitor, measures end-tidal carbon dioxide (ETCO) in exhaled breath. The CoSense Monitor aids in the detection hemolysis, which is the breakdown of red blood cells. When present in babies with jaundice, hemolysis is a dangerous condition that can lead to long-term developmental disabilities. The CoSense Monitor also aids in the detection of smoke inhalation and carbon monoxide poisoning. We have recently commenced commercial sales of the CoSense devices and sampling sets... More >>

Featured Report

Download Documentation 2015 10-K

Stock Quote

CAPN (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$0.80
Change (%)0.00 (0.00%)
Volume0
Data as of 02/17/17 3:57 p.m. ET

Recent News

More

DateTitle 
02/07/17Capnia to Present at the 19th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at the 19th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2017 at 8:00 AM ET at the Waldorf Astoria Hotel in New York City. The presentation will be webcast live ... 
Printer Friendly Version
12/27/16Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company
Combined Company to Focus on Advancing Novel, Late-Stage Asset for the Treatment of Prader-Willi Syndrome, a Devastating, Orphan Disease  Enrollment in a Phase II/III Clinical Trial Expected to Begin in Second Half of 2017 $8 Million Concurrent Financing; Sufficient to Fund Development Plan Through Key Value-Creating Mi... 
Printer Friendly Version
11/14/16Capnia Reports Third Quarter 2016 Financial Results
REDWOOD CITY, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the third quarter ended September 30, 2016. “We continue to see significant interest from hospitals in the US and other countries for the installation of our CoSense ETCO monitor, and we believe the developing installed base w... 
Printer Friendly Version
09/06/16Capnia to Present at Upcoming Investor Conferences
REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at two upcoming investor conferences: The Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016 at 12:05 PM ET at the Lotte New York Palace... 
Printer Friendly Version

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Capnia Inc posts new information to the site. Just enter your e-mail address and click Submit.

 
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources